1 The 10% long-term bleeding rate with just 12.5 mg of carvedilol daily is probably a 'too-good-to-be-true' scenario, especially given the mean HVPG reduction of 15–20% demonstrated in most ...

Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...